...

首页> 外文期刊>Japanese Journal of Clinical Oncology >BASIC SCIENCECombination Treatment of S-1 With CPT-11 to Overcome 5-Fluorouracil Resistance in Bladder Cancer (Japan)Immunohistochemicaln Analysis of Fas and FLIP in Prostate Cancers (South Korea)Phase 1 Clinical Trial of Novel HIG2-derived Epitope Peptide Vaccinen Treatment for Renal Cell Carcinoma (Japan)

【24h】

BASIC SCIENCECombination Treatment of S-1 With CPT-11 to Overcome 5-Fluorouracil Resistance in Bladder Cancer (Japan)Immunohistochemicaln Analysis of Fas and FLIP in Prostate Cancers (South Korea)Phase 1 Clinical Trial of Novel HIG2-derived Epitope Peptide Vaccinen Treatment for Renal Cell Carcinoma (Japan)

机译：基础科学S-1与CPT-11联合治疗可克服膀胱癌的5-氟尿嘧啶耐药性（日本）前列腺癌Fas和FLIP的免疫组织化学分析（韩国）新型HIG2衍生的表位肽疫苗疫苗治疗的第一阶段临床试验肾细胞癌（日本）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Japanese Journal of Clinical Oncology》 |2011年第3期|p.4-5|共2页
作者
M. Oya;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献

1. Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC [J] . Sugawara Shunichi, Nakagawa Kazuhiko, Yamamoto Nobuyuki, International journal of clinical oncology . 2019,第5期

机译：日本亚组分析铂基治疗后非小细胞肺癌患者S-1与多西紫杉醇的研究：East-LC
2. Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial [J] . Oyama Masafumi, Sugiyama Takayuki, Nozawa Masahiro, Japanese journal of clinical oncology. . 2017,第6期

机译：血管内皮生长因子受体酪氨酸激酶抑制剂术后先进肾细胞癌血管血管血管血管血管血管血管血管血管患者的疗效和安全性：多中心II期临床试验
3. Phase II study of S-1 monotherapy as a first-line treatment for elderly patients with advanced nonsmall-cell lung cancer: the Central Japan Lung Study Group trial 0404. [J] . Nishiyama O, Taniguchi H, Kondoh Y, Anti-cancer drugs . 2011,第8期

机译：S-1单一疗法作为晚期晚期非小细胞肺癌老年患者的一线治疗的II期研究：日本中部肺研究小组的0404试验。
4. Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC [O] . Shunichi Sugawara, Kazuhiko Nakagawa, Nobuyuki Yamamoto, -1

机译：日本亚组分析非小细胞肺癌铂类药物治疗后S-1与多西他赛的III期研究：EAST-LC
5. Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC [O] . Shunichi Sugawara, Kazuhiko Nakagawa, Nobuyuki Yamamoto, 2019

机译：日本亚组分析S-1阶段研究铂基治疗后非小细胞肺癌患者的二世左右二世枣：East-LC

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号